TD Asset Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-53,575
| Closed | -$5.75M | – | 1491 |
|
|
2023
Q1 | $5.75M | Buy |
53,575
+12,224
| +30% | +$1.31M | 0.01% | 714 |
|
|
2022
Q4 | $4.55M | Buy |
41,351
+24,751
| +149% | +$2.72M | 0.01% | 771 |
|
|
2022
Q3 | $955K | Buy |
+16,600
| New | +$955K | ﹤0.01% | 1191 |
|
|
2021
Q2 | – | Sell |
-34,465
| Closed | -$629K | – | 1590 |
|
|
2021
Q1 | $629K | Buy |
+34,465
| New | +$629K | ﹤0.01% | 1361 |
|